Pfizer (NYSE:PFE) and other pandemic-era favorites will be back in the investors’ crosshairs following the resignation of Dr.
That lawsuit has been on hold waiting for the patent board's ruling. Moderna had argued that Pfizer’s vaccine, Comirnaty, uses modified messenger RNA technology that Moderna had patented ...
March 5 - Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab won a round in their legal battle with Moderna (MRNA.O), opens new tab over COVID-19 vaccine patents on Wednesday ...
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
Federal investigators are investigating claims suggesting Pfizer delayed announcing test results of its Covid vaccine until after the 2020 presidential election, the Wall Street Journal reported ...
The NIH is funding at least 130 studies involving the mRNA technology in covid vaccines produced by Pfizer-BioNTech and ...
The Trump administration’s decision to cut funding for Gavi, as part of a broader reduction in foreign aid, may have ...
HealthDay on MSN13d
No Link Between COVID Vaccine During Pregnancy And Birth Defects, Study SaysThere were also no differences in birth defect risk between either the Moderna and the Pfizer/BioNTech vaccines, researchers ...
USPTO Finds Claims Of Two Of Moderna’s mRNA Patents Unpatentable: What’s Next In The Vaccine Wars? Legal News and Analysis - ...
Investing.com -- Shares of vaccine manufacturers Moderna Inc (BMV:MRNA) (NASDAQ:MRNA), Novavax Inc (NASDAQ:NVAX), and Pfizer Inc (NYSE:PFE) fell in today’s trading session, down 5%, 3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback